GE HealthCare Reports Strong Q1 Performance

GE HealthCare Technologies Inc. has announced a notable 3% year-on-year increase in its first-quarter revenue for fiscal 2025, totaling $4.8 billion. This performance not only exceeded expectations but also marked a significant step forward in the company's growth trajectory.

Net income saw an impressive surge of 50.8% compared to the same period in 2024, reaching $564 million. Additionally, diluted earnings per share (EPS) experienced a 51.85% annual increase to $1.23. In a move that underscores confidence in its financial health, GE HealthCare has unveiled a $1 billion share repurchase program.

Leadership's Perspective on Growth

"Our first-quarter results demonstrate robust execution and a strong start to the year, with significant growth in revenue, orders, and profit, particularly in the U.S. market," stated CEO Peter Arduini. He further highlighted the strategic acquisition of Nihon Medi-Physics, which is poised to enhance global access to next-generation radiopharmaceuticals, aligning with the company's precision care and growth acceleration strategies.

Market Response

Following the announcement, GE HealthCare's stock price rose by 2.81% in premarket trading, reaching $70 per share at 6:29 am ET, reflecting investor optimism about the company's future prospects.